Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
ADENOSINE-A2-RECEPTOR ACTIVATION AT REPERFUSION REDUCES INFARCT SIZE AND IMPROVES MYOCARDIAL WALL FUNCTION IN DOG HEART
Autore:
SCHLACK W; SCHAFER M; UEBING A; SCHAFER S; BORCHARD U; THAMER V;
Indirizzi:
HEINRICH HEINE UNIV,INST PHYSIOL 1,HERZ & KREISLAUFPHYSIOL ABT,MOORENSTR 5 W-4000 DUSSELDORF 1 GERMANY HEINRICH HEINE UNIV,INST PHYSIOL 1,HERZ & KREISLAUFPHYSIOL ABT,MOORENSTR 5 W-4000 DUSSELDORF 1 GERMANY HEINRICH HEINE UNIV,INST PHARMAKOL & TOXIKOL DUSSELDORF 1 GERMANY
Titolo Testata:
Journal of cardiovascular pharmacology
fascicolo: 1, volume: 22, anno: 1993,
pagine: 89 - 96
SICI:
0160-2446(1993)22:1<89:AAARRI>2.0.ZU;2-6
Fonte:
ISI
Lingua:
ENG
Soggetto:
CORONARY-ARTERY OCCLUSION; IRREVERSIBLE ISCHEMIC-INJURY; SUPEROXIDE ANION GENERATION; NO-REFLOW PHENOMENON; ADENOSINE RECEPTORS; INTRACORONARY ADENOSINE; HUMAN-NEUTROPHILS; POSTISCHEMIC MYOCARDIUM; INTRAVENOUS ADENOSINE; REVERSIBLE ISCHEMIA;
Keywords:
ADENOSINE; A2-RECEPTOR; REPERFUSION; MYOCARDIAL ISCHEMIA; INFARCT SIZE; REGIONAL MYOCARDIAL FUNCTION;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
59
Recensione:
Indirizzi per estratti:
Citazione:
W. Schlack et al., "ADENOSINE-A2-RECEPTOR ACTIVATION AT REPERFUSION REDUCES INFARCT SIZE AND IMPROVES MYOCARDIAL WALL FUNCTION IN DOG HEART", Journal of cardiovascular pharmacology, 22(1), 1993, pp. 89-96

Abstract

Reestablishment of blood supply to ischemic myocardium leads to biochemical and cellular changes which are believed to reduce the amount ofpotentially salvageable myocardium (reperfusion injury). In this situation, adenosine is known to have myocardial protective properties. Activation of adenosine A2-receptors may account for most of the beneficial effects of adenosine in reperfusion injury because A2-receptor activation mediates vasodilation, inhibits neutrophil adhesion to vascular endothelium and diminishes generation of free radicals by neutrophils, thus acting on some of the key mechanisms of reperfusion injury such as postischemic vascular dysfunction and neutrophil-mediated damage. Therefore, we investigated the effect of an intracoronary A2-agonist,CGS 21680, on regional postischemic myocardial function (measured as wall thickening) and infarct size [determined by triphenyltetrazolium chloride (TTC) staining]. Fourteen anesthetized open-chest dogs underwent 1-h left anterior descending artery (LAD) occlusion and 6-h reperfusion and were randomly assigned to receive intracoronary CGS 21680 orto serve as control. The drug was infused for 60 min starting 5 min before reperfusion with a concentration of 10(-7) M at a rate of 10 ml/min under anoxic conditions. The infusion was then continued for the first 55 min of reperfusion with 10(-6) M at a rate of 1 ml/min. Intracoronary infusion of CGS 21680 led to significant improvement in regional wall function in postischemic myocardium (p < 0.05 vs. control). Thickening fraction (percentage of baseline) increased from - 13.1 +/- 13.7% (mean +/- SD) during occlusion to 15.3 +/- 29.8% at 30 min of reperfusion in the CGS 21680 treatment group and remained at this level throughout the reperfusion period. In the control group, thickening fraction was - 23.7 +/- 16.2% during occlusion and did not recover duringreperfusion. A significant reduction in infarct size was noted in thetreatment group (11.5 +/- 7.9% of area at risk) as compared with the control group (28.6 +/- 11.4%, p < 0.05). These findings support the hypothesis that the protective effect of adenosine on reperfusion injury is not due to replenishment of the nucleoside pool but rather is induced by stimulation of the adenosine A2-receptor.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/12/20 alle ore 07:42:16